Safety of a live attenuated Erysipelothrix rhusiopathiae vaccine for swine

Veterinary Microbiology

Volumn 135, Issue 3-4, 2009, Pages 297-303

  Neumann, Eric J ^a   Grinberg, Alex ^a   Bonistalli, Kathryn N ^a   Mack, Hamish J ^a   Lehrbach, Philip R ^b   Gibson, Nicole ^b  

^a MASSEY UNIVERSITY   (New Zealand)

^b ZOETIS   (United States)

Author keywords

Erysipelas; Erysipelothrix rhusiopathiae; Live vaccine; Safety; Swine

Indexed keywords

BACTERIAL VACCINE; ERYSIPELOTHRIX RHUSIOPATHIAE VACCINE; LIVE VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM CULTURE; CONTROLLED STUDY; DRUG SAFETY; ERYSIPELAS; ERYSIPELOTHRIX INFECTION; ERYSIPELOTHRIX RHUSIOPATHIAE; NONHUMAN; SWINE; VACCINATION;

ADMINISTRATION, INTRANASAL; ANIMALS; BACTERIAL VACCINES; BODY TEMPERATURE; ERYSIPELOTHRIX; ERYSIPELOTHRIX INFECTIONS; NASAL MUCOSA; NOSE; SAFETY; SWINE; SWINE DISEASES; VACCINES, ATTENUATED; VIRULENCE; WEIGHT GAIN;

ERYSIPELOTHRIX RHUSIOPATHIAE; SUIDAE;

EID: 61849167521     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetmic.2008.09.059     Document Type: Article

References (14)

1. Anon., 2006. Target Animal Safety: Examination of Live Veterinary Vaccines in Target Animals for Absence of Reversion to Virulence (Brussels, Belgium, International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products), accessed on October 31, 2007 http://www.vichsec.org/pdf/05_2006/GL41-st3_rev.pdf.
2. Brooke C.J., and Riley T.V. Erysipelothrix rhusiopathiae: bacteriology, epidemiology and clinical manifestations of an occupational pathogen. J. Med. Microbiol. 48 (1999) 789-799
3. Dunbar S.A., and Clarridge J.E.III. Potential errors in recognition of Erysipelothrix rhusiopathiae. J. Clin. Microbiol. 38 (2000) 1302-1304
4. Eamens G.J., Forbes W.A., and Djordjevic S.P. Characterisation of Erysipelothrix rhusiopathiae isolates from pigs associated with vaccine breakdowns. Vet. Microbiol. 115 (2006) 329-338
5. Groschup M.H., and Timoney J.F. Modified Feist broth as a serum-free alternative for enhanced production of protective antigen of Erysipelothrix rhusiopathiae. J. Clin. Microbiol. 28 (1990) 2573-2575
6. Haesebrouck F., Pasmans F., Chiers K., Maes D., Ducatelle R., and Decostere A. Efficacy of vaccines against bacterial diseases in swine: what can we expect?. Vet. Microbiol. 100 (2004) 255-268
7. Harrington Jr. R., and Hulse D.C. Comparison of two plating media for the isolation of Erysipelothrix rhusiopathiae from enrichment broth culture. Appl. Microbiol. 22 (1971) 141-142
8. Opriessnig, T., Hoffman, L.J., Halbur, P.G., Harris, D.L., Gaul, S.B., 2002. Molecular characterization of recent and archived Erysipelothrix rhusiopathiae isolates. In: Iowa State University Swine Research Reports ASL-1811. Ames, Iowa, USA, Iowa State University, p. 2.
9. Opriessnig T., Hoffman L.J., Harris D.L., Gaul S.B., and Halbur P.G. Erysipelothrix rhusiopathiae: genetic characterization of midwest US isolates and live commercial vaccines using pulsed-field gel electrophoresis. J. Vet. Diagn. Invest. 16 (2004) 101-107
10. Quinn P.J., Carter M.E., Markey B.K., and Carter G.R. Clinical Veterinary Microbiology (1994), Wolfe Publishing, London 648 pp
11. Takahashi T., Nagamine N., Kijima M., Suzuki S., Takagi M., Tamura Y., Nakamura M., Muramatsu M., and Sawada T. Serovars of Erysipelothrix Strains Isolated from Pigs Affected with Erysipelas in Japan. J. Vet. Med. Sci. 58 (1996) 587-589
12. To H., and Nagai S. Genetic and antigenic diversity of the surface protective antigen proteins of Erysipelothrix rhusiopathiae. Clin. Vaccine Immunol. 14 (2007) 813-820
13. Wood R.L. Routes of elimination of Erysipelothrix insidiosa from infected swine. Am. J. Vet. Res. 28 (1967) 925-936
14. Wood R.L., and Henderson L.M. Erysipelas. In: Straw B.E., Zimmerman J.J., D'Allaire S., and Taylor D.J. (Eds). Diseases of Swine (2006), Blackwell Publishing Professional, Ames, Iowa, USA 629-638